论文部分内容阅读
The prospects of treating cancer by immunotherapy has been a dream of immunologists for many decades.The first success was the use of antibodies against specific cell surface antigens associated with certain cell lineages.The prominent examples are anti-CD20 antibodies for treatment B cell lymphomas and anti-Her-2 antibodies for cancers which have amplified this gene.